Home-administered fecal occult blood test for colorectal cancer screening among worksites in Taiwan

Preventive Medicine

Volumn 38, Issue 1, 2004, Pages 78-84

  Hou, Su I ^a   Chen, Pai Ho ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b CHENG CHING GENERAL HOSPITAL   (Taiwan)

Author keywords

Cancer screening; Chinese; FOBT; Home administered kit; Taiwan; Worksite

Indexed keywords

AGED; ARTICLE; BLOOD CHEMISTRY; CANCER SCREENING; CHINESE; COLORECTAL CANCER; DATA ANALYSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HOME MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PRIORITY JOURNAL; TAIWAN; WORKPLACE;

EID: 0348111396     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2003.09.031     Document Type: Article

References (15)

1. Department of Health, The Executive Yan, R.O.C. Health Statistics. Retrieved from World Wide Web site on May. 25, 2002. http://www.doh.gov.tw/lane/ statist/85/ .
2. Hardcastle J.D., Chamberlain J.O., Robinson M.H.E., Moss Sm., Amar S.S., Balfour T.W.et al. Randomized controlled trial of fecal-occult blood screening for colorectal cancer. Lancet. 348(9040):1996;1472-1477.
3. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomized study of screening for colorectal cancer with fecal occult blood test. Lancet. 348:1996;1467-1471.
4. Mandel J.S., Bond J.H., Church T.R., Snover D.C., Bradley G.M., Schuman L.M.et al. Reducing mortality from colorectal cancer by screening for fecal occult blood: Minnesota colon cancer control study. N. Engl. J. Med. 328:1993;1365-1371.
5. Newcomb P.A., Norfleet R.G., Storer B.E., Surawicz T.S., Marcus P.M. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl. Cancer Inst. 84:1992;1572-1575.
6. Selby J.V., Friedman G.D., Quesenberry C.P. Jr., Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 326:1992;653-657.
7. Winawer S.J., Flehinger B.J., Schottenfeld D., Miller D.G. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J. Natl. Cancer Inst. 85:1993;1311-1318.
8. Ries L.A., Wingo P.A., Miller D.S., Howe H.L., Weir H.K., Rosenberg H.M.et al. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer. 88(10):2000;2398-2424.
9. Hou S. Cancer screening beliefs and reactions to an innovative colorectal cancer screening kit among Chinese worksite population. Paper presented at the International Conference on Health Promotion, Oct. 25-27, 2003, Atlanta, GA, 2003.
10. Vernon S.W. Participation in colorectal cancer screening: a review. J. Natl. Cancer Inst. 89(19):1997;1406-1422.
11. Peterson S.K., Vernon S.W. A review of patient and physician adherence to colorectal cancer screening guidelines. Semin. Colon Rectal Surg. 11(1):2000;58-72.
12. Myers R.E., Ross E., Jepson C., Wolf T., Balshem A., Millner L.et al. Modeling adherence to colorectal cancer screening. Prev. Med. 23:1994;142-151.
13. Myers R.E., Ross E., Wolf T.A., Balshem A., Jepson C., Millner L. Behavioral interventions to increase adherence in colorectal cancer screening. Med. Care. 29:1991;1039-1050.
14. Lewis R.J., Lerman S.E., Schnatter A.R., Hughes J.I., Vernon S.W. Colorectal polyp incidence among polypropylene manufacturing workers. J. Occup. Med. 36:1994;174-181.
15. Hardcastle J.D., Farrands P.A., Balfour T.W., Chamberlain J., Amar S.S., Sheldon M.G. Controlled trial of fecal occult blood testing in the detection of colorectal cancer. Lancet. 2:1983;1-4.